SGS Life Sciences   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Geneva Switzerland (1878)
Status: No NME R&D (1878)

Organization Overview

First Clinical Trial
2005
NCT00354263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Clinical Pharmacology Unit Antwerp, Belgium | Clinical Pharmacology Unit at SGS Life Sciences - Antwerpen (Belgium) | Life Science Services SGS Belgium NV | SGS Antwerpen | SGS Antwerpen, Belgium | SGS Aster | SGS Aster-Cephac | SGS Aster-Cephac (CRO) | SGS Aster Life Science Services - Paris-France | SGS Aster, Paris, France | SGS Aster S.A.S. | SGS Aster S.A.S., Phase I Clinical Unit, France | SGS Belgium NV | SGS Clinical Pharmacology Unit | SGS Life Sciences | SGS Life Sciences, a division of SGS Belgium NV | SGS LSS Clinical Pharmacology Unit Antwerp | SGS LSS Clinical Pharmacology Unit Antwerpen | SGS LSS Clinical Pharmacology Unit - Antwerpen | SGS S.A. | SGS Stephens, Inc. Dallas Research Center | SGS Stuivenberg | SGS U.S. Testing Company Inc. | Stephens SGS, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

Key: SGS Life Sciences (1) Acquired (1)

ferric carboxymaltose (Injectafer) (1 trial)

sodium chloride (3 trials)

Drugs in Phase 3 Trials (1)

glucagon (1 trial)

Drugs in Phase 2 Trials (10)

ace393 (1 trial)

c21 (1 trial)

chf6001 (1 trial)

inactivated influenza vaccine (2 trials)

matrix-m1 (1 trial)

mva-np (1 trial)

p03277 (2 trials)

sar-407899 (1 trial)

sildenafil (viagra) (1 trial)

vis410 (1 trial)

Drugs in Phase 1 Trials (45)

Key: SGS Life Sciences (44) Acquired (1)

acetylsalicylic acid (aspirin) (2 trials)

adalimumab (humira) (1 trial)

artemether (1 trial)

atr-002 (1 trial)

chf 5993 (1 trial)

chf6333 (1 trial)

cimetidine (tagamet) (1 trial)

clopidogrel (plavix) (1 trial)

coartem (1 trial)

darexaban (5 trials)

elx-02 (2 trials)

eslicarbazepine acetate (aptiom) (1 trial)

eurartesim (1 trial)

fexinidazole (3 trials)

filgotinib (3 trials)

formoterol (foradil) (1 trial)

fr104 (1 trial)

gadoteric acid (Dotarem) (1 trial)

gft505 (2 trials)

glpg0187 (2 trials)

glpg-0259 (4 trials)

glpg-0492 (1 trial)

glpg-0555 (3 trials)

glpg0974 (1 trial)

glpg2222 (1 trial)

glpg2451 (1 trial)

glycopyrronium (robinul) (1 trial)

hepatitis b vaccine (recombinant) (recombivax) (1 trial)

ketoconazole (nizoral) (1 trial)

lag-3 (2 trials)

lopain (1 trial)

lumefantrine (Coartem) (2 trials)

moxifloxacin (avelox) (2 trials)

naltrexone (revia) (1 trial)

naproxen (naprosyn) (1 trial)

oxcarbazepine (trileptal) (1 trial)

p218 (1 trial)

pacritinib (Vonjo) (2 trials)

pantothenic acid (1 trial)

rifampin (1 trial)

sel-068 (1 trial)

sela-070 (1 trial)

solcitinib (2 trials)

tro19622 (1 trial)

urfamicin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthralgia (Phase 1)

Arthritis (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Bronchiectasis (Phase 1)

Campylobacter Infections (Phase 2)

Cardiovascular Diseases (Phase 1)

Communicable Diseases (Phase 1)

Cystic Fibrosis (Phase 1)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 3)

Diabetes Mellitus, Type 2 (Phase 1)

Dyslipidemias (Phase 1)

Epilepsies, Partial (Phase 1)

Epilepsy (Phase 1)

Erectile Dysfunction (Phase 2)

Fatigue (Phase 4)

Fibrosis (Phase 1)

Genetic Diseases, Inborn (Phase 1)

Hepatitis (Phase 1)

Hepatitis B (Phase 1)

Hypoglycemia (Phase 3)

Infections (Phase 2)

Influenza, Human (Phase 2)

Kidney Failure, Chronic (Phase 1)

Malaria (Phase 1)

Malaria, Falciparum (Phase 1)

Metabolic Diseases (Phase 1)

Multiple Sclerosis (Phase 1)

Multiple Sclerosis, Relapsing-Remitting (Phase 1)

Osteoarthritis, Knee (Phase 1)

Parasitemia (Phase 1)

Parasitic Diseases (Phase 1)

Primary Myelofibrosis (Phase 1)

Protozoan Infections (Phase 1)

Raynaud Disease (Phase 2)

Scleroderma, Diffuse (Phase 2)

Scleroderma, Systemic (Phase 2)

Sclerosis (Phase 2)

Trypanosomiasis (Phase 1)

Trypanosomiasis, African (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 61
  • # of Trial APIs: 58